patientMpower, an Irish healthtech company based in The Digital Hub, today announced the release of a new technology solution that enables home monitoring of patients with cystic fibrosis (CF), providing a treatment option that can reduce risks during the Covid-19 crisis.
The patientMpower for CF app allows people to measure vital signs relevant for their CF at home – including clinical grade measurement of their lung function and oxygen levels, along with recording of body weight and sputum volume. Patients’ information is immediately available for healthcare staff to view via a secure portal in the hospital.
For verified healthcare professionals
Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.
